Publications by authors named "Gregory Mattingly"

Claim this Profile

Mentions over time

Mentions by platform

Video Views

46,008

Total Likes

2,406

Extended Reach

1,103,589

Social Features

153
5
52-Week Open-Label Safety and Tolerability Study of Centanafadine Sustained Release in Adults With Attention-Deficit/Hyperactivity Disorder.
Gregory W Mattingly, Osman Turkoglu, Denise Chang, Caroline Ward, Taisa Skubiak

J Clin Psychopharmacol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Esketamine Monotherapy in Adults With Treatment-Resistant Depression: A Randomized Clinical Trial.
Adam Janik, Xin Qiu, Rosanne Lane, Vanina Popova, Wayne C Drevets, Gregory W Mattingly

JAMA Psychiatry· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-Term Symptomatic and Functional Remission with Paliperidone Palmitate 6-Monthly Treatment in Schizophrenia: A 3-Year Post-Hoc Analysis.
Joshua M Hamilton, Karen L Johnston, James Simples Jnr, Ibrahim Turkoz, Lisa Lim, Gregory Mattingly

Neuropsychiatr Dis Treat· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Aripiprazole Lauroxil: Development and Evidence-Based Review of a Long-Acting Injectable Atypical Antipsychotic for the Treatment of Schizophrenia.
Leslie Citrome, Christoph U Correll, Andrew J Cutler, Martin Dunbar, Amber R Hoberg, Gregory W Mattingly

Neuropsychiatr Dis Treat· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reply: the inclusion of methylphenidate in the WHO list of essential medicines is endorsed by millions of people with ADHD.
Samuele Cortese, David Coghill, Joerg M Fegert, Gregory W Mattingly, Luis A Rohde

Eur Child Adolesc Psychiatry· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Esketamine nasal spray versus quetiapine XR in adults with treatment-resistant depression: a secondary analysis of the ESCAPE-TRD randomized clinical trial.
Roger S McIntyre, Gregory Mattingly, Yordan Godinov, Jozefine Buyze, Ibrahim Turkoz

CNS Spectr· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Implications of Attention-Deficit/Hyperactivity Disorder in Adults: What New Data on Diagnostic Trends, Treatment Barriers, and Telehealth Utilization Tell Us.
Gregory Mattingly, Ann Childress

J Clin Psychiatry· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
AACAP Endorses the Inclusion of Methylphenidate in the WHO Model Lists of Essential Medicines.
Samuele Cortese, David Coghill, Gregory W Mattingly, Luis Augusto Rohde, Robyn P Thom

J Am Acad Child Adolesc Psychiatry· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Are all ADHD medications created equal? Exploring the differences that enable evening dosing.
Gregory W Mattingly, Julie A Carbray, Perry Roy, Frank A López

Postgrad Med· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Viloxazine extended-release capsules as an emerging treatment for attention-deficit/hyperactivity disorder in children and adolescents.
Vladimir Maletic, Gregory W Mattingly, Jami Earnest

Expert Rev Neurother· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
ESCAP endorses the inclusion of methylphenidate in the WHO model lists of essential medicines and in the Union list of critical medicines.
Samuele Cortese, David Coghill, Joerg M Fegert, Gregory W Mattingly, Luis A Rohde

Eur Child Adolesc Psychiatry· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expert consensus statement for telepsychiatry and attention-deficit hyperactivity disorder.
Jennifer Hong, Gregory W Mattingly, Julie A Carbray, Takesha V Cooper, Robert L Findling

CNS Spectr· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
WHO Essential Medicines List and methylphenidate for ADHD in children and adolescents - Authors' reply.
Samuele Cortese, David Coghill, Gregory W Mattingly, Luis A Rohde, Ian C K Wong

Lancet Psychiatry· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-Term Safety and Efficacy of Initial and Repeat Treatment Courses With Zuranolone in Adult Patients With Major Depressive Disorder: Interim Results From the Open-Label, Phase 3 SHORELINE Study.
Andrew J Cutler, Gregory W Mattingly, Susan G Kornstein, Scott T Aaronson, Robert Lasser

J Clin Psychiatry· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
WHO Model Lists of Essential Medicines: methylphenidate for ADHD in children and adolescents.
Samuele Cortese, David Coghill, Gregory W Mattingly, Luis A Rohde, Ian C K Wong

Lancet Psychiatry· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessing the educational needs of physicians in the management of patients with Tourette syndrome: results of a United States survey on practicing clinicians and caregivers.
Sylvie Stacy, Gregory D Salinas, Emily Belcher, Amanda Wilhelm, Jessica K Alexander, Gregory W Mattingly

CNS Spectr· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessing the educational needs of physicians in the management of patients with Tourette syndrome: results of a United States survey on practicing clinicians and caregivers - Corrigendum.
Sylvie Stacy, Gregory D Salinas, Emily Belcher, Amanda Wilhelm, Jessica K Alexander, Gregory W Mattingly

CNS Spectr· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Understanding the mechanism of action and clinical effects of neuroactive steroids and GABAergic compounds in major depressive disorder.
Andrew J Cutler, Gregory W Mattingly, Vladimir Maletic

Transl Psychiatry· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term safety and efficacy, including anhedonia, of vortioxetine for major depressive disorder: findings from two open-label studies.
Gregory W Mattingly, Oscar Necking, Simon Nitschky Schmidt, Elin Reines, Hongye Ren

Curr Med Res Opin· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effectiveness of vortioxetine for major depressive disorder in real-world clinical practice: US cohort results from the global RELIEVE study.
Gregory Mattingly, Elizabeth Brunner, Lambros Chrones, Debra F Lawrence, Kenneth Simonsen

Front Psychiatry· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Current and future nonstimulants in the treatment of pediatric ADHD: monoamine reuptake inhibitors, receptor modulators, and multimodal agents.
Andrew J Cutler, Gregory W Mattingly, Rakesh Jain, Welton O'Neal

CNS Spectr· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effectiveness of Vortioxetine in Patients With Major Depressive Disorder in Real-World Clinical Practice: Results of the RELIEVE Study.
Gregory W Mattingly, Hongye Ren, Michael Cronquist Christensen, Martin A Katzman, Mircea Polosan

Front Psychiatry· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adult Patient Preferences for Long-Acting ADHD Treatments: A Discrete Choice Experiment.
M Janelle Cambron-Mellott, Jaromir Mikl, Joana E Matos, Jennifer G Erensen, Kathleen Beusterien, Gregory W Mattingly

Patient Prefer Adherence· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A clinician's guide to ADHD treatment options.
Gregory W Mattingly, Joshua Wilson, Anthony L Rostain

Postgrad Med· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis